Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance.
Journal: Urologic oncology
Published: June 30, 2024
A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma.
Journal: BMC urology
Published: August 12, 2023
Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder Substitution.
Journal: Kidney international reports
Published: May 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
Journal: Urologic oncology
Published: March 29, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Journal: The Lancet. Oncology
Published: February 15, 2023
An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
Journal: The American Journal of dermatopathology
Published: December 09, 2022
Healthcare Resource Utilization After Surgical Treatment of Cancer: Value of Minimally Invasive Surgery.
Journal: Surgical endoscopy
Published: December 29, 2021
Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.
Journal: Urologic oncology
Published: March 14, 2021
Last Updated: 09/26/2026